The French medicines agency has approved the marketing of Sativex in France. The medicine has been derived from cannabis, for the first time in France and is also the first pharmaceutical drug based on cannabis.

The medicine will be produced by Britain's GW Pharmaceuticals. The use of the medicine will be permitted for the cure of muscle spasms linked with multiple sclerosis against the serious contractions resistant to other treatments.

Neurologists and hospital physicians will be permitted to prescribe the medicine.

Sativex, a mouth spray, consists of two marijuana's two best known components. The components are delta 9-THC and cannabidiol.

As per the website of the company, the medicine has already been launched in 11 countries approved in over a dozen of other countries.

As per the ministry, the medicine will strike the French market in 2015.

Use of marijuana is illegal. But, permitting doctors to prescribe it in certain cases is necessary to curb some of the diseases.

In recent Years, several countries have been let-up control on the trade of cannabis-based products for medical use. The U. S. state of Colorado permitted the first legal recreational drug of the nation marijuana shops to open starting this year. The official information has been revealed by the French health ministry on Thursday.